VBI Vaccines (VBIV) - Analyst Comments

VBI Vaccines (VBIV) – Analyst Comments

Jun 7, 2022 05:45 AM "Remain Encouraged by VBI-1901's Performance" - Oppenheimer Reiterates VBI Vaccines (VBIV) at Outperform with $8 Price Target
Feb 28, 2022 06:16 AM Oppenheimer Reiterates VBI Vaccines (VBIV) at Outperform, ACIP Recommendation Sets Stage for PreHevbrio Coverage
Dec 29, 2021 03:49 AM
Aug 26, 2020 07:18 PM
Jul 31, 2020 01:15 PM
Jun 23, 2020 06:57 AM
Mar 31, 2020 10:11 AM
Sep 11, 2019 07:25 AM
Jun 19, 2019 09:06 AM
Jun 17, 2019 03:16 PM
Jun 17, 2019 02:07 PM
Jun 17, 2019 12:46 PM
Jan 16, 2019 06:13 AM
May 10, 2018 11:13 AM
Nov 15, 2017 10:40 AM
Nov 1, 2017 08:24 AM